1. Home
  2. RNST vs STVN Comparison

RNST vs STVN Comparison

Compare RNST & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RNST

Renasant Corporation

HOLD

Current Price

$40.01

Market Cap

3.7B

Sector

Finance

ML Signal

HOLD

Logo Stevanato Group S.p.A.

STVN

Stevanato Group S.p.A.

HOLD

Current Price

$17.56

Market Cap

3.7B

ML Signal

HOLD

Company Overview

Basic Information
Metric
RNST
STVN
Founded
1904
1949
Country
United States
Italy
Employees
N/A
N/A
Industry
Major Banks
Containers/Packaging
Sector
Finance
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
3.7B
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
RNST
STVN
Price
$40.01
$17.56
Analyst Decision
Strong Buy
Buy
Analyst Count
3
3
Target Price
$43.00
$25.67
AVG Volume (30 Days)
573.2K
563.4K
Earning Date
04-28-2026
05-07-2026
Dividend Yield
2.31%
0.39%
EPS Growth
N/A
N/A
EPS
2.07
N/A
Revenue
N/A
N/A
Revenue This Year
$31.72
$9.67
Revenue Next Year
$4.67
$9.99
P/E Ratio
$19.32
$27.15
Revenue Growth
N/A
N/A
52 Week Low
$32.63
$12.89
52 Week High
$42.11
$28.00

Technical Indicators

Market Signals
Indicator
RNST
STVN
Relative Strength Index (RSI) 60.30 74.51
Support Level $36.72 $13.58
Resistance Level $39.99 $26.94
Average True Range (ATR) 0.92 0.78
MACD -0.04 0.27
Stochastic Oscillator 48.94 91.61

Price Performance

Historical Comparison
RNST
STVN

About RNST Renasant Corporation

Renasant Corp operates as a holding company for Renasant Bank, a Mississippi banking corporation, and its subsidiary, Renasant Insurance, Inc. It has two reportable segments: Community banks and Wealth management. With its Community Banks segment, the company provides a range of financial services to individuals and small businesses. The Wealth management segment provides a range of services, including money management and retirement planning. The majority of the company's revenue is driven by lending activities in its community banks segment.

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.

Share on Social Networks: